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doi:10.1016/j.fjs.2012.05.001Summary Background: Neck lymph node metastasis is the most critical factor influencing
survival and prognosis of oral squamous cell carcinoma (OSCC). The risk factors for contralat-
eral neck metastasis are still controversial.
Purpose: To identify the risk factors of contralateral neck metastasis of OSCC.
Methods: The 683 previously untreated OSCC patients managed at the China Medical University
Hospital from January 1997 to December 2006 were reviewed. We statically analyzed the risk
factors potentially related to contralateral neck lymph node metastasis.
Results: Mouth floor invasion and midline crossing tumors were statistically significant for the
presence of pretreatment cN2c. Midline-crossing tumors had statistically significant impact on
the presence of pathologic contralateral neck lymph node metastasis (pN2c). Mouth floor inva-
sion and poorly differentiated tumor showed statistically significant impact on contralateral
neck relapse for OSCC patients who underwent only ispilateral neck dissection. Poorly differ-
entiated tumor showed statistically significant impact on contralateral neck relapse for
patients with contralateral neck dissection.
Conclusion: Mouth floor invasion, midline crossing tumors, poorly differentiated tumors had
a high risk in contralateral neck metastasis.
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Neck lymph node metastasis is the most significant
prognostic and survival factor in patients with oral
squamous cell carcinoma (OSCC).1 Patients with patho-
logically negative cervical lymph nodes are believed to
have a relatively good prognosis. In contrast, the
outcome of patients with lymph node metastasis occur-
ring after excision or radiotherapy of the primary tumor
is poor.2 Factors that predict contralateral lymph node
metastasis in OSCC patients remain controversial. Pre-
dicting contralateral neck metastasis may improve the
prognosis of these patients. This study was aimed to
examine possible predictive clinicopathologic factors for
contralateral neck metastasis in surgically-treated
primary OSCC.2. Setting and ethics
This study was held in the tertiary referral hospital [China
Medical University Hospital (CMUH), head and neck cancer
center] in Taiwan. Ethical approval was granted by the
institutional review board, CMUH, Taichung, Taiwan.3. Patients and methods
A total of 683 previously untreated OSCC patients
managed at the CMUH from January 1997 to December
2006 were reviewed. The tumor was staged in accordance
with the American Joint Committee on Cancer sixth
edition TNM Staging Classification. All patients were
treated with surgery with or without adjuvant therapy.
The inclusion criteria were as follows: (1) patients with
biopsy-confirmed diagnosis of SCC of the oral tongue,
buccal mucosa, gum, palate, and mouth floor; (2) patients
not previously submitted for treatment; and (3) patients
for curative surgery as first treatment. The exclusion
criteria included at least one of the following: (1)
contraindication for surgery; (2) distant metastasis at the
time of admission; (3) presence of other simultaneous
primary tumors; and (4) patients who refused surgical
treatment.
Selective neck dissection I-III was performed on all T2-4
tumors without presence of clinically positive nodal
disease, while selective neck dissection I-V was performed
in the presence of clinically positive nodal disease.
Whether the tumor crossed the midline or there was floor of
the mouth invasion was decided via a computed tomog-
raphy scan and physical examination. Postoperative adju-
vant therapy was applied to patients with either one of the
major risk factors (i.e., close or positive section margin or
extracapsular spread) or more than two minor risk factors
(i.e., perineural invasion, lympho-vascular permeation,
N2, T3). The kind of postoperative adjuvant therapy was
chosen via the Radiotherapy-Oncology-Head and Neck
Surgery Combined Conference according to the criteria of
CMUH. All patients were followed-up at least for 24 months
or until death and they were all retrospectively reviewed
under the Institutional Review Board approval of the China
Medical University Hospital.4. Statistical analysis
Multivariate and univariate logistic regression analysis
combined with stepwise selection techniques was used to
examine the predictive clinicopathologic factors for
contralateral neck metastasis. A p< 0.05 was considered
statistically significant. Age, sex, tumor site, primary tumor
laterality, TNM status, clinical N status, pathologic T status,
ipsilateral pathologic N status, tumor stage, status of
residual disease, histopathologic differentiation, adjuvant
therapy, local relapse, extra-capsular spread by lymph
node metastasis, perineural/lympho-vascular invasion, and
type of adjuvant therapy were evaluated for association
with contralateral neck metastasis. Survival curves were
calculated by the Kaplan-Meier method with log rank
analysis.
Clinical and pathologic variables were evaluated via the
predictive value (univariate) for the occurrence of metas-
tasis in the contralateral lymph nodes. The odds ratio was
the association measurement used to evaluate metastases
by each factor under study. Multivariate analysis, followed
by stepwise selection, was conducted after adjusting for
the effect by dummy variables, to verify the maintenance
of such variables for risks of metastasis.
5. Results
Of the 683 patients with SCC of the oral cavity who fulfilled
the inclusion criteria, 624 were male and 356 were aged
50 years. The primary tumor location was on the oral
tongue in 298 patients (43.6%), buccal mucosa in 283
(41.4%), gums in 46 (6.7%), lips in 24 (3.5%), mouth floor in
19 (2.8%), and on the palate in 13 (1.9%). There were seven
pretreatment cN2c patients.
Mouth floor invasion and midline crossing tumors were
statistically significant for the presence of pretreatment
cN2c after statistical analysis (Table 1). All seven cN2c
patients underwent bilateral neck dissection. Five of them
were further confirmed by pathology as bilateral neck
metastasis (pN2c). Another patient had contralateral neck
relapse later. Of the 677 non-cN2c patients, 48 underwent
prophylactic bilateral neck dissection. Post-operatively,
8 of the 48 elective bilateral neck dissection were patho-
logically further diagnosed to have bilateral neck lymph
node metastasis (pN2c).
There were 13 pathologic N2c cases. After statistical
analysis, midline-crossing tumors had statistically signifi-
cant impact on the presence of pathologic contralateral
neck lymph node metastasis (pN2c; Table 1). Contralateral
neck relapse was diagnosed in 26 patients, one of whom
was previously diagnosed as a case of cN2c and underwent
bilateral neck dissection. Eighteen of the 26 cases under-
went ipsilateral neck dissection for curative therapy, while
seven had a wait-and-see policy for their neck nodes
(Fig. 1).
Mouth floor invasion and poor differentiation of tumor
showed statistically significant impact on contralateral
neck relapse for oral SCC patients who received ipsilateral
neck dissection. Poorly differentiated tumor showed
statistically significant impact on contralateral neck relapse
(Table 2).
Table 1 Risk factors for the presence of cN2c and pN2c. Data are expressed as odds ratio (95% confidence interval).
Number of cN/pN Category cN (nZ 7) pN (nZ 13)
Variable Univariate Multivariate Univariate Multivariate
Age 50 1.0 1.0
>50 1.2 (0.3,5.5) 1.8 (0.4, 8)
cT stage cT1,cT2 1.0 1.0 1.0
cT3,cT4 11.6 (1.4,97.2)* 4.7 (0.5,43.0) 22 (0.1, 129)
pT stage pT1,pT2 1.0
pT3,pT4 5.7 (0.6, 49.7)
cN stage cN0 1.0
cN1 1.3 (0.2, 7.1)
Mouth floor invasion No 1.0 1.0 1.0
Yes 52.9 (6.3,446.3)# 12.4 (1.2,124.5)* 5.4 (1, 30.2)
Cross-midline tumor No 1.0 1.0 1.0 1.0
Yes 52.9 (6.3,446.3)# 13.1 (1.3,130.9)* 6.0 (1.1, 33.4)* 6.0 (1.1,33.4)*
Tongue base invasion No 1.0
Yes 0.3 (0.3, 79.1)
Tumor differentiation Well/Moderate 1.0 1.0
Poor 5.3 (0.6, 47) 3.7 (0.8, 30.7)
Extracapsular spreading No 1.0 1.0
Yes 6.4 (0.7, 56.3) 3.3 (0.6, 8.1)
Perineral invasion No 1.0 1.0
Yes 1.7 (0.4, 7.7) 3.4 (1.4, 30.2)
Lymphovascular permeation No 1.0 1.0
Yes 4(0.6, 29.2) 5.0(1.5, 8.4)
*Z p< 0.05; #Z p< 0.01.
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eral neck relapse had poorer outcomes. Advanced OSCC
patients initially presenting with mouth floor invasion or
tumor with midline crossing who underwent contralateral
neck treatment had better outcomes. Patients with
advanced poorly differentiated OSCC had better survival
outcomes if they underwent contralateral neck dissection
initially. There was no survival benefit for advanced OSCC
with perineural invasion or lympho-vascular permeation if
they initially underwent contralateral neck dissection.
The odds ratio was the association measurement used to
evaluate metastases in accordance with each factor under
study. By multivariate analysis, tumor with invasion to the
mouth floor exhibited a 12.4-fold higher risk of associationTotal 683 OSCC patients 
Pretreatment cN2c non-cN2c
n = 7                                n = 676 
Bilateral ND Bilateral ND Ipsilateral ND Observation 
n = 7                         n = 48        n = 456       n = 172 
pN2c non-pN2c pN2c non-pN2c
n = 5      n = 2             n = 8         n = 40 
n = 1        n = 0                 n = 0        n = 18           n = 7 
Figure 1 Contralateral neck relapse.with cN2c, while midline-crossing tumor showed a 13.1-fold
higher risk of association with cN2c (Table 2). Midline-
crossing tumors exhibited a 6.0-fold higher risk of associa-
tion with pN2c by multivariate analysis (Table 1).
For cases with contralateral neck dissection, poorly
differentiated tumors exhibited a 3.9-fold higher risk of
contralateral neck relapse by multivariate analysis (Table
2). In patients with ipsilateral neck dissection, mouth
floor invasion showed a 4.9-fold higher risk of contralateral
neck relapse, while poorly differentiated tumors showed an
8.0-fold higher risk by multivariate analysis (Table 2).
In this study, considering 13 cases of pathology-
confirmed contralateral neck metastasis from 55 cases of
contralateral neck dissection and the 25 relapse cases from
628 observation cases of the contralateral neck, the
frequency of contralateral neck metastasis and occult
contralateral neck metastasis was 5.6% (38/683) and 4.9%
(33/676), respectively.6. Discussion
A review of related articles shows that the frequency of
metastasis to contralateral cervical lymph nodes of oral
carcinomas varies from 4% to 16.1%.1e8 The definition of
contralateral neck metastasis includes the presence of
initial contralateral lymph node involvement, occult
contralateral neck lymph node metastasis confirmed via
pathology study, and contralateral neck relapse. In this
study, the frequency for contralateral neck metastasis and
occult contralateral neck metastasis was 5.6% (38/683) and
4.9% (33/676), respectively.
Table 2 Risk factors of contralateral neck relapse in the three groups*, by multivariate analysis. Data are expressed as odds
ratio (95% confidence interval).
Variables Category Contralateral neck
dissection (nZ 55)
Without contralateral
neck dissection (nZ 628)
Ipsilateral neck
dissection (nZ 711)
Mouth floor invasion No 1.0 1.0 1.0
Yes 2.7 (0.8, 9.2) 3.5 (1.0, 12.5) 4.9 (1.2, 21.0)*
Cross-medline tumor No 1.0 1.0 1.0
Yes 1.9 (0.5, 6.8) 2.0 (0.5, 7.8) 1.5 (0.3, 8.6)
Tongue base invasion No 1.0 1.0 1.0
Yes 2.9 (0.8, 11.0) 2.7 (0.6, 11.6) 3.5 (0.8, 16.1)
Tumor differentiation Well/moderate 1.0 1.0 1.0
Poor 3.9 (1.2, 12.8)* 3.3 (1.4, 11.1)* 8.0 (1.5, 43.5)*
Perineural invasion No 1.0 1.0 1.0
Yes 1.5 (0.5, 4.3) 1.6 (0.5, 5.1) 0.8 (0.2, 2.8)
Lymphovascular permeation No 1.0 1.0 1.0
Yes 2.4 (0.8, 7.8) 3.2 (0.9, 11.0) 3.7 (1.0, 13.8)
Contralateral neck dissection: patient who received contralateral neck dissection; without contralateral neck dissection: there was no
contralateral neck dissection performed; ipsilateral neck dissection: patients who received ipsilateral neck dissection with or without
contralateral neck dissection.
*Z p< 0.05.
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metastasis, and state that patients with clinically positive
ipsilateral neck nodes also have a higher risk of contralateral
neck occult metastasis.5 Kurita et al reported 14.7% contra-
lateral neck metastasis,4 while Gonzalez-Garcia et al
reported 9.8% ipsilateral and 4.4% contralateral neck recur-
rence.7 Lim et al reported 4% occult contralateral neck
metastasis in early stage oral tongue SCC,6 and Koxalski et al
reported 14% contralateral neck metastasis.3
The 5-year overall survival rate for the contralateral
neck relapse group is 24.7%, while for the noncontralateral
neck relapse group it is 61% (pZ 0.0001). Koo et al also
showed lower 5-year disease-specific and overall survival
rates of OSCC patients with positive contralateral neck
metastasis.5
There are a few reports in the literature with regard to
the factors involved in the risk of contralateral metastasis.
Koxalski et al reported that the clinical stage, tumor
crossing of the midline, and floor of mouth involvement are
predictors of contralateral metastasis, and give a figure of
14% contralateral neck metastasis.3 Kurita et al reported
that the T stage, number of ipsilateral lymph node metas-
tasis, and histopathologic grade are independent and
significant predictors of contralateral neck metastasis.4
Gonzalez-Garcia et al showed that histopathologic grading
and peritumor inflammation are statistically significantly
related to contralateral neck recurrence.7 Lim et al
reported no survival benefits of elective contralateral neck
dissection for early-stage oral tongue SCC,6 while Hiratsuka
et al reported that the mode of carcinoma invasion,
intensity of lymphocytic infiltration, degree of differenti-
ation, number of mitotic figures, and type of growth are
predictors of occult neck lymph node metastasis.2 Godden
et al reported that tumor thickness of more than 5 mm is
a strong predictor for neck recurrence of OSCC,1 while Koo
et al reported that advanced (T3) OSCC, midline-crossing
tumor, and positive ipsilateral neck node have higher risks
of contralateral occult neck metastasis.5From the data here, midline-crossing tumor
(pZ 0.0208) and mouth floor invasion (pZ 0.0196) are
significantly related to the presence of cN2c and pN2c.
This is consistent with other studies.3,5 All pN2c patients
were histopathologic and had clinically advanced tumor
stage (T3), which shows statistically significant
(pZ 0.0235) correlation to N2c by univariate analysis,
although not by multivariate analysis. This result is similar
to those reported previously.4,5 For clinical practice, our
study further reinforces the predictive value of midline-
crossing tumor, mouth floor invasion tumor, and
advanced tumor stage (T3). Therefore, prophylactic
contralateral neck dissection is highly recommended for
these patients.
The other part of our study focused on contralateral
neck relapse after treatment. Because contralateral neck
dissection remains controversial, the patients were grou-
ped according to neck dissection performance. Among the
26 contralateral neck relapse patients, only one came from
the primary contralateral neck dissection group. Eighteen
were from the ipsilateral neck dissection group and seven
came from the non-neck dissection group. For patients who
had undergone contralateral neck dissection with either
prophylactic or curative intent, poorly differentiated
tumors were statistically significant having contralateral
neck relapse. For those patients who had undergone ipsi-
lateral neck dissection, mouth floor invasion (pZ 0.0025)
and tumor differentiation (pZ 0.0228) showed statistical
significance for contralateral neck relapse.
From the above description, prophylactic contralateral
neck dissection actually reduced the risk of contralateral
neck failure of OSCC. Prophylactic contralateral neck
dissection is therefore suggested for primary oral tumors
with mouth floor invasion or midline crossing, or at
advanced tumor stage (T3). Adjuvant therapy such as
radiotherapy for the contralateral neck region is an alter-
native for clinicians if there is tumor invasion of the mouth
floor or if the tumor is poorly differentiated.
Factors influencing contralateral neck metastasis 877. Conclusions
Contralateral neck metastasis is a critical factor influencing
the survival of patients with OSCC. The contralateral side of
the neck is a potentially preventable site of recurrence in
tumors of the oral cavity. This study shows that prophy-
lactic contralateral neck dissection is recommended for
oral cancer with the presence of midline crossing and
mouth floor invasion. Adjuvant therapy on the contralateral
side of the neck is suggested for poorly differentiated
tumors or if there is mouth floor tumor invasion or tumor
with midline crossing.References
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